RxNorm 2105785

Dermalone (neomycin 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 2105785 unique identifier include: Dermalone (neomycin 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment (10782096), neomycin 0.025 MG/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 MG/MG Topical Ointment [Dermalone] (12372080) and Dermalone (neomycin (as neomycin sulfate) 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment (10782100).

RxNorm Atom ID: 10782096 - Prescribable Name
Dermalone (neomycin 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment

RXCUI:
2105785 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
10782096 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
Concept Description:
Dermalone (neomycin 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment - Description of concept identifier
Term Type (TTY):
PSN - Term type in source with name and description
Term Type Name:
Prescribable Name - Name of term type in source
Term Type Description:
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. - Description of term type in source
Code:
2105785 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240401F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12372080 - Semantic Branded Drug
neomycin 0.025 MG/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 MG/MG Topical Ointment [Dermalone]

RXCUI:
2105785 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
12372080 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
Concept Description:
neomycin 0.025 MG/MG / nystatin 100 UNT/MG / thiostrepton 2.5 UNT/MG / triamcinolone 0.001 MG/MG Topical Ointment [Dermalone] - Description of concept identifier
Term Type (TTY):
SBD - Term type in source with name and description
Term Type Name:
Semantic Branded Drug - Name of term type in source
Term Type Description:
Ingredient + Strength + Dose Form + Brand Name - Description of term type in source
Code:
2105785 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240401F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12372080 Attributes

PropertyValueExplanation
RXN AI{2105777} 7300RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI{2105778} 1365970RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI{328439} 10761RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI{646455} 7597RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{2105777} 7299RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM{2105778} 1365970RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM{328439} 10759RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM{646455} 7597RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{2105777} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{2105778} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{328439} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM{646455} AISource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED11/28/2023Date the RxNorm atom became obsolete
RXTERM FORMOintmentThe RxTerm dose form name for this drug

RxNorm Atom ID: 10782100 - Synonym
Dermalone (neomycin (as neomycin sulfate) 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment

RXCUI:
2105785 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
10782100 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
NO - This drug IS NOT part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.
Concept Description:
Dermalone (neomycin (as neomycin sulfate) 2.5 MG / nystatin 100,000 UNT / thiostrepton 2500 UNT / triamcinolone acetonide 1 MG per 1 GM) Topical Ointment - Description of concept identifier
Term Type (TTY):
SY - Term type in source with name and description
Term Type Name:
Synonym - Name of term type in source
Term Type Description:
Synonym of another TTY, given for clarity. - Description of term type in source
Code:
2105785 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
O
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
- Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240401F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.